PL2219658T3 - Kompozycja oparta na bakteriach probiotycznych w połączeniu z prebiotykiem i jej zastosowanie w zapobieganiu i/lub leczeniu schorzeń oddechowych i/lub infekcji oraz do polepszenia funkcjonalności jelit - Google Patents

Kompozycja oparta na bakteriach probiotycznych w połączeniu z prebiotykiem i jej zastosowanie w zapobieganiu i/lub leczeniu schorzeń oddechowych i/lub infekcji oraz do polepszenia funkcjonalności jelit

Info

Publication number
PL2219658T3
PL2219658T3 PL08857635T PL08857635T PL2219658T3 PL 2219658 T3 PL2219658 T3 PL 2219658T3 PL 08857635 T PL08857635 T PL 08857635T PL 08857635 T PL08857635 T PL 08857635T PL 2219658 T3 PL2219658 T3 PL 2219658T3
Authority
PL
Poland
Prior art keywords
prebiotic
infections
association
prevention
improvement
Prior art date
Application number
PL08857635T
Other languages
English (en)
Inventor
Giovanni Mogna
Gian Paolo Strozzi
Luca Mogna
Original Assignee
Probiotical Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probiotical Spa filed Critical Probiotical Spa
Publication of PL2219658T3 publication Critical patent/PL2219658T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Nutrition Science (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL08857635T 2007-12-03 2008-12-03 Kompozycja oparta na bakteriach probiotycznych w połączeniu z prebiotykiem i jej zastosowanie w zapobieganiu i/lub leczeniu schorzeń oddechowych i/lub infekcji oraz do polepszenia funkcjonalności jelit PL2219658T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT002260A ITMI20072260A1 (it) 2007-12-03 2007-12-03 Una composizione a base di batteri probiotici in associazione con un prebiotico e suo uso nella prevenzione e/o nel trattamento di patologie e/o infezioni respiratorie e nel miglioramento della funzionalita intestinale.
EP08857635.0A EP2219658B1 (en) 2007-12-03 2008-12-03 Composition based on probiotic bacteria in association with a prebiotic and use thereof in the prevention and/or treatment of respiratory pathologies and/or infections and in the improvement of intestinal functionality
PCT/EP2008/066700 WO2009071578A1 (en) 2007-12-03 2008-12-03 Composition based on probiotic bacteria in association with a prebiotic and use thereof in the prevention and/or treatment of respiratory pathologies and/or infections and in the improvement of intestinal functionality

Publications (1)

Publication Number Publication Date
PL2219658T3 true PL2219658T3 (pl) 2014-01-31

Family

ID=40315520

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08857635T PL2219658T3 (pl) 2007-12-03 2008-12-03 Kompozycja oparta na bakteriach probiotycznych w połączeniu z prebiotykiem i jej zastosowanie w zapobieganiu i/lub leczeniu schorzeń oddechowych i/lub infekcji oraz do polepszenia funkcjonalności jelit

Country Status (8)

Country Link
US (1) US20110027243A1 (pl)
EP (1) EP2219658B1 (pl)
BR (1) BRPI0819323B8 (pl)
ES (1) ES2434833T3 (pl)
IT (1) ITMI20072260A1 (pl)
PL (1) PL2219658T3 (pl)
RU (1) RU2491081C2 (pl)
WO (1) WO2009071578A1 (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20042189A1 (it) 2004-11-16 2005-02-16 Anidral Srl Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale
WO2011044934A1 (en) * 2009-10-14 2011-04-21 Probiotical S.P.A Probiotic bacteria strains enabling of hydrolyzing prebiotic fibers and symbiotic compositions thereof
GB201110095D0 (en) * 2011-06-15 2011-07-27 Danisco Method of treatment
FR2989002B1 (fr) * 2012-04-10 2015-05-15 Beepratte Lab Compositions a base de probiotiques et d'un complexe beepollen/argile, leur preparation et leurs utilisations en nutrition et therapeutique
RU2506308C1 (ru) * 2012-07-25 2014-02-10 Вячеслав Михайлович Абрамов КОНСОРЦИУМ ПРОБИОТИЧЕСКИХ ШТАММОВ Lactobacillus rhamnosus И Lactobacillus plantarum ДЛЯ ИЗГОТОВЛЕНИЯ БАКТЕРИАЛЬНОГО ПРЕПАРАТА И ЗАКВАСКИ ПРЯМОГО ВНЕСЕНИЯ ДЛЯ ПРОИЗВОДСТВА ФЕРМЕНТИРОВАННОГО МОЛОКА И ФЕРМЕНТИРОВАННОГО СВЕКОЛЬНОГО СОКА
US9171525B2 (en) * 2013-02-26 2015-10-27 Nvidia Corporation Graphics processing unit with a texture return buffer and a texture queue
US9165396B2 (en) 2013-02-26 2015-10-20 Nvidia Corporation Graphics processing unit with a texture return buffer and a texture queue
ITUB20153106A1 (it) * 2015-08-13 2017-02-13 Probiotical Spa Composizione di batteri lattici per uso nel trattamento delle infezioni causate da Propionibacterium acnes e in particolare per l'acne
RS57471B1 (sr) 2015-12-17 2018-09-28 Institut Za Molekularnu Genetiku I Geneticko Inzenjerstvo Univerzitet U Beogradu Nova probiotička starter kultura za humanu i animalnu primenu
ITUB20159330A1 (it) 2015-12-22 2017-06-22 Roelmi Hpc S R L Composizioni probiotiche e loro uso
PL3691666T3 (pl) * 2017-10-04 2024-09-02 Chr. Hansen A/S Kompozycja farmaceutyczna zawierająca kombinację probiotyku i prebiotyku do leczenia zahamowania wzrostu
CN111493322B (zh) * 2020-05-15 2023-01-17 苏州普瑞森生物科技有限公司 一种微囊化益生菌及其制备方法和应用
IL301145A (en) 2020-09-11 2023-05-01 Marvelbiome Inc Methods and uses of microbiome compositions
IT202100015398A1 (it) * 2021-06-11 2022-12-11 Probiotical Spa Ceppi di batteri probiotici per uso in un metodo di trattamento preventivo o in un metodo di trattamento coadiuvante per le infezioni respiratorie virali
CN114262680B (zh) * 2022-01-04 2023-07-04 澳优乳业（中国）有限公司 菌株及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6241983B1 (en) * 1994-10-28 2001-06-05 Metagenics, Inc. Bacteria-and fiber-containing composition for human gastrointestinal health
GB2369777B (en) * 2000-10-05 2004-10-27 St Ivel Ltd Food products with antimicrobial lactic acid bacteria
DE20202562U1 (de) * 2002-02-19 2002-05-23 Orthomol pharmazeutische Vertriebs GmbH, 40764 Langenfeld Mikronährstoffkombinationsprodukt mit Pro- und Prebiotika
US20050074442A1 (en) * 2002-03-13 2005-04-07 Natarajan Ranganathan Compositions and methods for augmenting kidney function
EP2336294A3 (en) * 2002-07-22 2014-07-02 Agtech Products, Inc. Lactobacillus strains and uses therefor
BRPI0418986A (pt) * 2004-08-05 2007-12-11 Anidral Srl cepas bacterianas bifidobacterium produtoras de ácido fólico, formulações e seus usos
ITMI20042189A1 (it) * 2004-11-16 2005-02-16 Anidral Srl Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale
EP2012596A1 (en) * 2006-05-03 2009-01-14 Anidral S.R.L. Symbiotic composition comprising non-digestible polysaccharides and bifidobacteria which metabolize them and its uses

Also Published As

Publication number Publication date
ITMI20072260A1 (it) 2009-06-04
BRPI0819323B8 (pt) 2021-05-25
RU2010126327A (ru) 2012-01-10
ES2434833T3 (es) 2013-12-17
EP2219658A1 (en) 2010-08-25
RU2491081C2 (ru) 2013-08-27
WO2009071578A1 (en) 2009-06-11
BRPI0819323B1 (pt) 2020-10-13
US20110027243A1 (en) 2011-02-03
EP2219658B1 (en) 2013-08-21

Similar Documents

Publication Publication Date Title
PL1773361T3 (pl) Kompozycje oparte na bakteriach probiotycznych i ich zastosowanie w profilaktyce i/lub leczeniu patologii i/lub zakażeń układu oddechowego oraz poprawie funkcji jelit
PL1981516T3 (pl) Zastosowanie mikroorganizmów probiotycznych w leczeniu i zapobieganiu otyłości i pokrewnym zaburzeniom
IL249165A0 (en) Use of an antigen-mhc complex to prepare drugs for the prevention and treatment of autoimmune conditions
SI2170848T1 (sl) Derivati pirazinona in njihova uporaba pri zdravljenju bolezni pljuč
IL200278A (en) Use of aclidinium for the manufacture of a drug for use in the treatment or prevention of respiratory illness and pharmacist's preparation for the treatment or prevention of respiratory illness
UA100551C2 (en) Synbiotic mixture
ZA200800206B (en) "One-way valve for medical infusion lines and the like"
AP2965A (en) Therapeutic compositions and the use thereof
EP2205300A4 (en) MEDICAL INHALATION DEVICES AND COMPONENTS THEREOF
AP2490A (en) Therapeutic compositions and the use thereof
PL2435056T3 (pl) Lactobacillus pentosus wytwarzający bakteriocyny i jego zastosowanie w kompozycjach żywnościowych i farmaceutycznych
PL2252290T3 (pl) Kompozycja farmaceutyczna do zastosowania w leczeniu i/lub zapobieganiu chorobom kostno-stawowym
GB0611131D0 (en) Nicotine inhalation therapies - smoking cessation and other medical uses
ZA201001616B (en) Cleaning and/or treatment compositions
PL2087094T3 (pl) Lactobacillus fermentum ess-1, dsm17851 i jego zastosowanie do leczenia i/lub zapobiegania kandydozie i zakażeniom dróg moczowych
ZA200900235B (en) Prevention and treatment of otitis media with non-pathogenic bacterial strains
PT2388317T (pt) Um gene que codifica um mutante de glucocinase humana, e as suas utilizações no tratamento ou prevenção de doença
PL2209527T3 (pl) Kompozycje farmaceutyczne zawierające probiotyki L.acidophilus i Bifidobacterium lactis do stosowania w leczeniu zaburzenia czynnościowego jelit
PL2068899T3 (pl) Lactobacillus acidophilus do zastosowania w zmniejszaniu częstości występowania i czasu trwania zakażeń dróg oddechowych
ZA201003037B (en) Use of 3, 11b-cis-dihydrotettabenazine in the treatment of multiple sclerosis and autoimmune myelitis
PL1847256T3 (pl) Kompozycje przeciwbakteryjne do leczenia infekcji górnych i dolnych dróg oddechowych
IL201426A0 (en) Drug combination and its use in the treatment of muscle loss
IL205675A0 (en) Oxazolidinones for the treatment and/or prophylaxis of heart failure
LT2421380T (lt) Sumažinto cholesterolio pieno produktas, skirtas naudoti kepenų ligų gydymui ir (arba) profilaktikai
GB0612748D0 (en) Treatment and/or prevention of inflammatory lung disease